Incyte (INCY) Change in Cash (2010 - 2026)
Incyte (INCY) reported Change in Cash of $363.3 million for Q1 2026, up 43.06% on a YoY basis from $253.9 million in Q1 2025, and down 43.49% quarter-over-quarter from $642.8 million in Q4 2025.
Incyte (INCY) Change in Cash (2010 - 2026) Analysis & Trends
Incyte has reported Change in Cash for 17 years, with the latest figure at $363.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 43.06% year-over-year to $363.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 208.2% YoY), and the FY2025 full-year result was $1.4 billion, up 192.43% from the prior year.
- Change in Cash for Q1 2026 stood at $363.3 million, down from $642.8 million in the prior quarter.
- The five-year high for Change in Cash was $642.8 million in Q4 2025, with the low at -$2.4 billion in Q2 2024.
- Historically, Change in Cash has averaged $82.6 million across 5 years, with a median of $253.9 million in 2025.
- The largest YoY upside for Change in Cash was 2894.73% in 2024 against a maximum downside of 860.76% in 2024.
- Incyte's Change in Cash stood at $260.9 million in 2022, then slumped by 105.26% to -$13.7 million in 2023, then surged by 2894.73% to $383.6 million in 2024, then jumped by 67.57% to $642.8 million in 2025, then plunged by 43.49% to $363.3 million in 2026.
- The last three Change in Cash figures came in at $363.3 million (Q1 2026), $642.8 million (Q4 2025), and $500.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 363.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363.28 Mn |
| Dec 31, 2025 | 642.82 Mn |
| Sep 30, 2025 | 500.04 Mn |
| Jun 30, 2025 | 13.43 Mn |
| Mar 31, 2025 | 253.94 Mn |
| Dec 31, 2024 | 383.61 Mn |
| Sep 30, 2024 | 316.92 Mn |
| Jun 30, 2024 | -2.36 Bn |
| Mar 31, 2024 | 132.61 Mn |
| Dec 31, 2023 | -13.73 Mn |
| Sep 30, 2023 | 96.11 Mn |
| Jun 30, 2023 | 310.07 Mn |
| Mar 31, 2023 | -130.35 Mn |
| Dec 31, 2022 | 260.90 Mn |
| Sep 30, 2022 | 255.20 Mn |
| Jun 30, 2022 | 178.57 Mn |
| Mar 31, 2022 | 199.30 Mn |
| Dec 31, 2021 | 58.46 Mn |
| Sep 30, 2021 | 201.44 Mn |
| Jun 30, 2021 | 127.65 Mn |